Follow the people · Insider
Mark Hopman
Mark Hopman files insider transactions with the SEC as a chief commercial officer of Beta Bionics (BBNX). We hold 8 disclosed purchases and sales filed since 31 January 2025, 2 of them in the last 90 days.
- Files forBBNX
- Disclosed buys and sells8 in all, 2 in the last 90 days
- Last disclosure3 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 29 January 2025 — 2 September 2026Chief Commercial Officer · Beta Bionics (BBNX)41 Form 4 lines · source: SEC Form 4
Everything they disclosed
41 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 5,327 shares of Beta BionicsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 1,258 shares of Beta BionicsSEC Form 425 June 2026Common Stock · traded 24 June 2026 · filed 25 June 2026
- ▼ sold on the open market 275 shares of Beta BionicsSEC Form 45 June 2026Common Stock · traded 4 June 2026 · filed 5 June 2026
- ▼ sold on the open market 5,329 shares of Beta BionicsSEC Form 43 June 2026Common Stock · traded 2 June 2026 · filed 3 June 2026
- ▼ sold on the open market 856 shares of Beta BionicsSEC Form 416 March 2026Common Stock · traded 2 December 2025 · filed 16 March 2026
- ▼ sold on the open market 2,061 shares of Beta BionicsSEC Form 416 March 2026Common Stock · traded 4 December 2025 · filed 16 March 2026
- ▼ sold on the open market 856 shares of Beta BionicsSEC Form 416 March 2026Common Stock · traded 2 December 2025 · filed 16 March 2026
- ▼ sold on the open market 2,061 shares of Beta BionicsSEC Form 416 March 2026Common Stock · traded 4 December 2025 · filed 16 March 2026
- was granted 91,520 shares of Beta Bionics (a derivative holding)SEC Form 413 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 13 March 2026
- was granted 91,520 shares of Beta Bionics (a derivative holding)SEC Form 413 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 13 March 2026
- ▼ sold on the open market 353 shares of Beta BionicsSEC Form 45 March 2026Common Stock · traded 4 March 2026 · filed 5 March 2026
- ▼ sold on the open market 353 shares of Beta BionicsSEC Form 45 March 2026Common Stock · traded 4 March 2026 · filed 5 March 2026
- was granted 109,105 shares of Beta BionicsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 834 shares of Beta BionicsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- was granted 58,749 shares of Beta Bionics (a derivative holding)SEC Form 43 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 58,749 shares of Beta Bionics (a derivative holding)SEC Form 43 March 2026Employee Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 109,105 shares of Beta BionicsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 834 shares of Beta BionicsSEC Form 43 March 2026Common Stock · traded 2 March 2026 · filed 3 March 2026
- exercised options over 656 shares of Beta Bionics (a derivative holding)SEC Form 48 September 2025Employee Stock Option (right to buy) · traded 4 September 2025 · filed 8 September 2025
- exercised options over 4,093 shares of Beta Bionics (a derivative holding)SEC Form 48 September 2025Employee Stock Option (right to buy) · traded 4 September 2025 · filed 8 September 2025
- exercised options over 11,411 shares of Beta Bionics (a derivative holding)SEC Form 48 September 2025Employee Stock Option (right to buy) · traded 5 September 2025 · filed 8 September 2025
- exercised options over 656 shares of Beta BionicsSEC Form 48 September 2025Common Stock · traded 4 September 2025 · filed 8 September 2025
- exercised options over 4,093 shares of Beta BionicsSEC Form 48 September 2025Common Stock · traded 4 September 2025 · filed 8 September 2025
- ▼ sold on the open market 6,818 shares of Beta BionicsSEC Form 48 September 2025Common Stock · traded 4 September 2025 · filed 8 September 2025
- exercised options over 11,411 shares of Beta BionicsSEC Form 48 September 2025Common Stock · traded 5 September 2025 · filed 8 September 2025
- ▼ sold on the open market 11,411 shares of Beta BionicsSEC Form 48 September 2025Common Stock · traded 5 September 2025 · filed 8 September 2025
- ▼ sold on the open market 848 shares of Beta BionicsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- exercised options over 16,158 shares of Beta Bionics (a derivative holding)SEC Form 420 August 2025Employee Stock Option (right to buy) · traded 19 August 2025 · filed 20 August 2025
- exercised options over 16,158 shares of Beta BionicsSEC Form 420 August 2025Common Stock · traded 19 August 2025 · filed 20 August 2025
- ▼ sold on the open market 16,158 shares of Beta BionicsSEC Form 420 August 2025Common Stock · traded 19 August 2025 · filed 20 August 2025
- ▼ sold on the open market 238 shares of Beta BionicsSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- ▼ sold on the open market 551 shares of Beta BionicsSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- ▼ sold on the open market 79 shares of Beta BionicsSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- was granted 52,000 shares of Beta Bionics (a derivative holding)SEC Form 43 March 2025Employee Stock Option (right to buy) · traded 27 February 2025 · filed 3 March 2025
- was granted 35,000 shares of Beta BionicsSEC Form 43 March 2025Common Stock · traded 27 February 2025 · filed 3 March 2025
- was granted 83,242 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 37,229 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 17,765 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 39,424 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 47,775 shares of Beta Bionics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- was granted 47,775 shares of Beta Bionics (a derivative holding)SEC Form 431 January 2025Employee Stock Option (right to buy) · traded 29 January 2025 · filed 31 January 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.